Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Total Non-Current Liabilities (2020 - 2026)

Privia Health has reported Total Non-Current Liabilities over the past 6 years, most recently at $9.9 million for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities rose 210.82% year-over-year to $9.9 million; the TTM value through Dec 2025 reached $9.9 million, up 210.82%, while the annual FY2025 figure was $9.9 million, 210.82% up from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $9.9 million at Privia Health, up from $5.3 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $45.7 million in Q4 2021 and troughed at $3.2 million in Q4 2024.
  • A 5-year average of $15.8 million and a median of $8.5 million in 2023 define the central range for Total Non-Current Liabilities.
  • Biggest five-year swings in Total Non-Current Liabilities: tumbled 79.67% in 2023 and later soared 210.82% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $45.7 million in 2021, then crashed by 79.25% to $9.5 million in 2022, then plummeted by 41.42% to $5.6 million in 2023, then tumbled by 42.62% to $3.2 million in 2024, then soared by 210.82% to $9.9 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for PRVA at $9.9 million in Q4 2025, $5.3 million in Q3 2025, and $4.1 million in Q2 2025.